Ten years single institutional experience of treatment for advanced laryngeal cancer in Kyoto University

Acta Oto-Laryngologica

Volumn 130, Issue SUPPL. 563, 2010, Pages 68-73

  Kada, Shinpei ^a   Hirano, Shigeru ^a   Tateya, Ichiro ^a   Kitamura, Morimasa ^a   Ishikawa, Seiji ^a   Kanda, Tomoko ^b   Asato, Ryo ^b   Tanaka, Shinzo ^c   Ito, Juichi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^c OSAKA RED CROSS HOSPITAL   (Japan)

Author keywords

Glottic cancer; Supraglottic cancer; Therapeutic outcomes

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; JAPAN; LARYNGECTOMY; LARYNX CANCER; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; NECK DISSECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; SKIN METASTASIS; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

EID: 77957549545     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.3109/00016489.2010.492237     Document Type: Article

References (16)

1. Ganly I, Patel SG, Matsuo J, Singh B, Kraus DH, Boyle J, et al. Predictors of outcome for advancedstage supraglottic laryngeal cancer. Head Neck 2009;31:1489-95.
2. Sobin LH, Wittekind Ch, editors. 2002. UICC, TNM classification of malignant tumors. Sixth edition. New York: Wiley-Liss.
3. Tateya I, Hirano S, Kojima H, Omori K, Shoji K, Mitsumori M, et al. Hyperfractionated radiotherapy for T2 glottic cancer for preservation of the larynx. Eur Arch Otorhinolaryngol 2006;263:144-8.
4. Tamura Y, Tanaka S, Asato R, Hirano S, Yamashita M, Tamaki H, et al. Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years. Acta Otolaryngol Suppl 2007;557:62-5.
5. Spector JG, Sessions DG, Chao KS, Hanson JM, Simpson JR, Perez CA. Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery. Head Neck 1999;21:116-23.
6. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 2001;19:4029-36.
7. Sessions DG, Lenox J, Spector GJ, Newland D, Simpson J, Haughey BH, et al. Management of T3N0M0 glottic carcinoma: therapeutic outcomes. Laryngoscope 2002;112:1281-8.
8. Spector GJ, Sessions DG, Lenox J, Newland D, Simpson J, Haughey BH. Management of stage IV glottic carcinoma: therapeutic outcomes. Laryngoscope 2004;114:1438-46.
9. Delaere P, Goeleven A, Poorten VV, Hermans R, Hierner R, Vranckx J. Organ preservation surgery for advanced unilateral glottic and subglottic cancer. Laryngoscope 2007;117:1764-9.
10. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-8.
11. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. D. Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991;324:1685-90.
12. Genden EM, Ferlito A, Rinaldo A, Silver CE, Fagan JJ, Suárez C, et al. Recent changes in the treatment of patients with advanced laryngeal cancer. Head Neck 2008;30:103-10.
13. Matsuo JM, Patel SG, Singh B, Wong RJ, Boyle JO, Kraus DH, et al. Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx. Ann Surg 2003;238:412-22.
14. Périé S, Hugentobler A, Susini B, Balogova S, Grahek D, Kerrou K, et al. Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2007;137:647-53.
15. Haugen H, Johansson KA, Ejnell H, Edström S, Mercke C. Accelerated radiotherapy for advanced laryngeal cancer. Acta Oncol 2005;44:481-9.
16. Papadas TA, Alexopoulos EC, Mallis A, Jelastopulu E, Mastronikolis NS, Goumas P. Survival after laryngectomy: a review of 133 patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol 2010;267:1095-101.